This week the Dutch-Belgian biotech company Galapagos agreed an unprecedented deal with the American pharmaceutical giant Gilead. The deal has guaranteed its independence for at least 10 years and boosted its bank balance. For now the fish seems to be safe from the sharks.
DutchNews.nl has been free for 13 years, but now we are asking our readers to help. Your donation will enable us to keep providing you with fair and accurate news and features about all things Dutch.
Donate via Ideal, credit card or Paypal.